March 26, 2008--As part of ArthroCare Sports Medicine's recent entry into the Foot and Ankle arena, ArthroCare(R) Corp. (Nasdaq: ARTC) announced that it has launched early stage clinical and pre-clinical research work for treating diabetic foot ulcers and is encouraged by preliminary results reported by physicians. There are an estimated 18 million Americans living with diabetes today and each year at least 5% of that population develops foot ulcers as an effect of the disease. The Centers for Medicare and Medicaid Services (CMS) report that up to 30% of those suffering from diabetic foot ulcers eventually require amputation and that even for those whose ulcers heal, there is a 66% recurrence rate in that patient population. Indeed, such ulcers are far and away the most common condition leading to lower extremity amputations in the world today... ArthroCare's Press Release -
